Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • INDIA MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2028

INDIA MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2028

The India medical thawing system market is estimated to project a CAGR of 10.51% during the forecast period, 2022-2028, and is expected to reach a revenue of $6.58 million by 2028.

INDIA MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2028

India Medical Thawing System Market by Sample Type (Blood, Embryo, Ovum, Semen) Market by End-user (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical & Biotech Companies, Other End-users)

Request free sample

The India medical thawing system market is estimated to project a CAGR of 10.51% during the forecast period, 2022-2028, and is expected to reach a revenue of $6.58 million by 2028.

The booming blood plasma market in India is one of the key factors offering growth opportunities for the medical thawing system market. This is because of the increasing foreign direct investment (FDI) between April 2000 and June 2018 in clinics and hospitals, as per the Department of Industrial Policy and Promotion (DIPP), which further benefits the health infrastructure. At the same time, as per the WHO, India requires around 900,000 liters of plasma proteins annually. Earlier, the country outsourced proteins from multinational companies like Baxter. At present, several domestic companies are undertaking manufacturing. For instance, Reliance Life Sciences launched its first set of five plasma proteins, including virus inactivated plasma (ReliPlasma), fibrin sealant (ReliSeal), anti-hemophilic factor VIII (HemoRel), immunoglobulin (ImmunoRel), and albumin (AlbuRel).

India Medical Thawing System Market

To know more about this report, request a free sample copy

Furthermore, emerging technologies like 3D cell culture are witnessing increased adoption in regenerative medicine, toxicity screening, and drug discovery, given their ability to mimic the in vivo environment of diseased cells. India is one of the prominent 3D cell culture markets in Asia-Pacific. As a result, it is a conducive market for medical thawing systems, given their role in facilitating high cell viability. Besides, the Indian pharmaceutical industry has been recording steady growth over the years, thereby becoming a potential market for cell culture technologies.

The India medical thawing system market scope includes the assessment of sample type and end-user. The end-user segment is further sub-segmented into tissue banks, hospitals, pharmaceutical & biotech companies, blood banks, and other end-users.

Hospitals house the injured and the sick and administer surgical and medical treatment alongside disease diagnosis. They are the major end-users of thawing systems, given the presence of competent medical professionals for handling medical equipment and their multi-facility healthcare treatments. Also, medical thawing systems are used for several emergency cases that need a blood transfusion. Moreover, hospitals became the centers for vaccine administration during the pandemic. Vaccines need thawing systems to unfreeze.

A tissue is a group of cells with similar structures, functioning together as a unit. A tissue bank collects and recovers human tissues for medical research, allograft transplantation, and education. It is also a designated area wherein tissue storage requires cryogenic conditions for clinical usage. Tissue banks collect samples from donors and freeze them in cold storage for future medical treatments. One of the largest non-profit tissue banks is the American Association of Tissue Banks (AATB).

A cryobank, semen bank, and sperm bank is a facility that sells, purchases, and preserves human semen. The sample is preserved through cryopreservation. The sample is warmed using a thawing system before the fertilization process.

Some of the key firms in the India medical thawing system market are Sartorius AG, Terumo Corporation, Danaher Corporation, Thermo Fisher Scientific Inc, Cardinal Health, etc.

Danaher Corporation markets, manufactures, and designs commercial, industrial, professional, and medical products and services globally. It operates through three segments, environmental & applied solutions, diagnostics, and life sciences. The company has a varied consumer base globally, with research & development, distribution, sales, and manufacturing facilities and services in over 50 countries. It has its headquarters in Washington, the United States.

One of its key products, VIA Thaw Dry Automated Thawers, automates thawing to eliminate waterborne contamination risks and streamline processes with dry thawing technology.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2028
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Sample Type, End-User
Companies Analyzed

Cardinal Health, Danaher Corporation, Sartorius AG, Terumo Corporation, Thermo Fisher Scientific Inc

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON MEDICAL THAWING SYSTEM MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • PESTLE ANALYSIS
    4. MARKET BY SAMPLE TYPE
      • BLOOD
      • EMBRYO
      • OVUM
      • SEMEN
    5. MARKET BY END-USER
      • BLOOD BANKS
      • HOSPITALS
      • TISSUE BANKS
      • PHARMACEUTICAL & BIOTECH COMPANIES
      • OTHER END-USERS
    6. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
        • DIVESTITURES
      • COMPANY PROFILES
        • CARDINAL HEALTH
        • DANAHER CORPORATION
        • SARTORIUS AG
        • TERUMO CORPORATION
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – INDIA MEDICAL THAWING SYSTEM

    TABLE 2: INDIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: INDIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 4: INDIA MEDICAL THAWING SYSTEM MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: INDIA MEDICAL THAWING SYSTEM MARKET, BY END-USER, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 6: LIST OF MERGERS & ACQUISITIONS

    TABLE 7: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 8: LIST OF DIVESTITURES                        

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: INDIA MEDICAL THAWING SYSTEM MARKET, GROWTH POTENTIAL, BY SAMPLE TYPE, IN 2021

    FIGURE 5: INDIA MEDICAL THAWING SYSTEM MARKET, BY BLOOD, 2022-2028 (IN $ MILLION)

    FIGURE 6: INDIA MEDICAL THAWING SYSTEM MARKET, BY EMBRYO, 2022-2028 (IN $ MILLION)

    FIGURE 7: INDIA MEDICAL THAWING SYSTEM MARKET, BY OVUM, 2022-2028 (IN $ MILLION)

    FIGURE 8: INDIA MEDICAL THAWING SYSTEM MARKET, BY SEMEN, 2022-2028 (IN $ MILLION)

    FIGURE 9: INDIA MEDICAL THAWING SYSTEM MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 10: INDIA MEDICAL THAWING SYSTEM MARKET, BY BLOOD BANKS, 2022-2028 (IN $ MILLION)

    FIGURE 11: INDIA MEDICAL THAWING SYSTEM MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)

    FIGURE 12: INDIA MEDICAL THAWING SYSTEM MARKET, BY TISSUE BANKS, 2022-2028 (IN $ MILLION)

    FIGURE 13: INDIA MEDICAL THAWING SYSTEM MARKET, BY PHARMACEUTICAL & BIOTECH COMPANIES, 2022-2028 (IN $ MILLION)

    FIGURE 14: INDIA MEDICAL THAWING SYSTEM MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)       

    1. MARKET BY SAMPLE TYPE
      • BLOOD
      • EMBRYO
      • OVUM
      • SEMEN
    2. MARKET BY END-USER
      • BLOOD BANKS
      • HOSPITALS
      • TISSUE BANKS
      • PHARMACEUTICAL & BIOTECH COMPANIES
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type